Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II for hypotension in kidney transplant
NCT04529005Phase 4Completed
- Sponsor
- University of Illinois Chicago
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in hypotension, Distributive shock (DS), sponsored by University of Illinois Chicago. Started Aug 2020; status: completed.
02
Drugs
Angiotensin II
03
Conditions
hypotensionDistributive shock (DS)
Beyond the preview
Go deeper on NCT04529005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04529005.